Articles related to Clinical Pharmacology

Digoxin’s narrow therapeutic window and individual patient variability necessitate careful monitoring and consideration in clinical practice.

CGRP inhibitors have shown promise in reducing migraine days and improving quality of life, but their wide-ranging effects throughout the body warrant careful consideration and long-term monitoring.

Nearly 70% of 340B contract pharmacies are now associated with pharmacy benefit managers, potentially shifting the program’s focus away from its original intent of supporting safety-net providers.

An estimated 5% of U.S. adults have consumed at least one potentially hepatotoxic herbal supplement in the past month, raising concerns about liver health risks associated with unregulated botanical products.

CBD gummies offer a convenient administration method with prolonged effects, but their delayed onset presents unique considerations for therapeutic use. Understanding the pharmacokinetics and individual factors affecting CBD absorption is essential for optimizing patient outcomes.

In a phase 3 trial involving 5,338 cisgender women in South Africa and Uganda, twice-yearly lenacapavir injections demonstrated complete prevention of HIV infection, significantly outperforming daily oral medication regimens.